Where Will the Next Generation of Stroke Treatments Come From?
article has not abstract
Vyšlo v časopise:
Where Will the Next Generation of Stroke Treatments Come From?. PLoS Med 7(3): e32767. doi:10.1371/journal.pmed.1000224
Kategorie:
Research in Translation
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000224
Souhrn
article has not abstract
Zdroje
1. LearyMC
SaverJL
2003 Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 16 280 285
2. DonnanGA
FisherM
MacleodM
DavisSM
2008 Stroke. Lancet 371 1612 1623
3. MergenthalerP
DirnaglU
MeiselA
2004 Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19 151 167
4. DonnanG
BaronJ
DavisS
SharpF
2006 The Ischaemic Penumbra: history, current status and implications for therapy. New York Informa Health Care Inc
5. PROGRESS Collaborative Group 2001 Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 1033 1041
6. KizerJR
DahlofB
KjeldsenSE
JuliusS
BeeversG
2005 Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 45 46 52
7. AmarencoP
BogousslavskyJ
CallahanA3rd
GoldsteinLB
HennericiM
2006 High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 549 559
8. GrangerCB
WhiteHD
BatesER
OhmanEM
CaliffRM
1994 A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 74 1220 1228
9. VahediK
HofmeijerJ
JuettlerE
VicautE
GeorgeB
2007 Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6 215 222
10. LanghorneP
WilliamsBO
GilchristW
HowieK
1993 Do stroke units save lives? Lancet 342 395 398
11. FeiginVL
LawesCM
BennettDA
AndersonCS
2003 Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 43 53
12. BonitaR
BeagleholeR
1989 Increased treatment of hypertension does not explain the decline in stroke mortality in the United States, 1970–1980. Hypertension 13 I69 73
13. BejotY
Ben SalemD
OssebyGV
CouvreurG
DurierJ
2009 Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Neurology 72 346 353
14. ConnollySJ
EzekowitzMD
YusufS
EikelboomJ
OldgrenJ
2009 Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361 1139 1151
15. KwonHM
KimBJ
ParkJH
RyuWS
KimCK
2009 Significant association of metabolic syndrome with silent brain infarction in elderly people. J Neurol
16. LovshinJA
DruckerDJ
2009 Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5 262 269
17. DienerHC
2006 Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Int J Stroke 1 4 8
18. HoksbergenAW
MajoieCB
HulsmansFJ
LegemateDA
2003 Assessment of the collateral function of the circle of Willis: three-dimensional time-of-flight MR angiography compared with transcranial color-coded duplex sonography. AJNR Am J Neuroradiol 24 456 462
19. MiteffF
LeviCR
BatemanGA
SprattN
McElduffP
2009 The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 132 2231 2238
20. BiswasA
TiwariAK
RanjanR
MeenaA
AkhterMS
2009 Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients. Ann Hematol 88 473 478
21. AdamskiMG
TurajW
SlowikA
Wloch-KopecD
WolkowP
2009 A-G-4G haplotype of PAI-1 gene polymorphisms −844 G/A, HindIII G/C, and −675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease. Acta Neurol Scand 120 94 100
22. GilliganAK
ThriftAG
SturmJW
DeweyHM
MacdonellRA
2005 Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? Cerebrovasc Dis 20 239 244
23. DawsonTM
DawsonVL
2006 Taming the clot-buster tPA. Nat Med 12 993 994
24. BluhmkiE
ChamorroA
DavalosA
MachnigT
SauceC
2009 Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 8 1095 1102
25. HackeW
KasteM
BluhmkiE
BrozmanM
DavalosA
2008 Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359 1317 1329
26. SuEJ
FredrikssonL
GeyerM
FolestadE
CaleJ
2008 Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14 731 737
27. LadenvallC
GilsA
JoodK
BlomstrandC
DeclerckPJ
2007 Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation. Arterioscler Thromb Vasc Biol 27 955 962
28. BrounsR
HeylenE
SheorajpandayR
WillemseJL
KunnenJ
2009 Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients. Clin Neurol Neurosurg 111 165 170
29. SemeraroF
AmmolloCT
SemeraroN
ColucciM
2009 Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins. Haematologica 94 819 826
30. BajzarL
NesheimME
TracyPB
1996 The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 88 2093 2100
31. BirdE
TamuraJ
BostwickJS
SteinbacherTE
StewartA
2007 Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats? Thromb Res 120 549 558
32. SmithWS
SungG
StarkmanS
SaverJL
KidwellCS
2005 Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 1432 1438
33. BoseA
HenkesH
AlfkeK
ReithW
MayerTE
2008 The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 29 1409 1413
34. MacleodMR
FisherM
O'CollinsV
SenaES
DirnaglU
2009 Good laboratory practice: preventing introduction of bias at the bench. Stroke 40 e50 52
35. SenaE
van der WorpHB
HowellsD
MacleodM
2007 How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 30 433 439
36. STAIR 1999 Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 2752 2758
37. van der WorpHB
SenaES
DonnanGA
HowellsDW
MacleodMR
2007 Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 130 3063 3074
38. BernardS
2006 Therapeutic hypothermia after cardiac arrest: now a standard of care. Crit Care Med 34 923 924
39. SalussoliaCL
NalwalkJW
HoughLB
2007 Improgan-induced hypothermia: a role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature. Brain Res 1152 42 48
40. AslamiH
SchultzMJ
JuffermansNP
2009 Potential applications of hydrogen sulfide-induced suspended animation. Curr Med Chem 16 1295 1303
41. SesslerDI
2009 Defeating normal thermoregulatory defenses: induction of therapeutic hypothermia. Stroke 40 e614 621
42. HenningerN
BouleyJ
NelliganJM
SicardKM
FisherM
2007 Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 27 1632 1642
43. SinghalAB
BennerT
RoccatagliataL
KoroshetzWJ
SchaeferPW
2005 A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 36 797 802
44. HoltmaatA
SvobodaK
2009 Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci 10 647 658
45. CurtisMA
ErikssonPS
FaullRL
2007 Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol 34 528 532
46. KuhlmannT
MironV
CuoQ
WegnerC
AntelJ
2008 Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131 1749 1758
47. JohanssonBB
2000 Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 31 223 230
48. MinnerupJ
HeidrichJ
WellmannJ
RogalewskiA
SchneiderA
2008 Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke 39 1855 1861
49. DaadiMM
MaagAL
SteinbergGK
2008 Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One 3 e1644
50. OttHC
MatthiesenTS
GohSK
BlackLD
KrenSM
2008 Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14 213 221
51. DirnaglU
SchwabJM
2009 Brain-immune interactions in acute and chronic brain disorders. Neuroscience 158 969 971
52. BatchelorPE
LiberatoreGT
WongJY
PorrittMJ
FrerichsF
1999 Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19 1708 1716
53. LoEH
2008 A new penumbra: transitioning from injury into repair after stroke. Nat Med 14 497 500
54. WhisnantJ
1997 Modeling of risk factors for ischemic stroke. The Willis Lecture. Stroke 28 1840 1844
55. LouviA
Arboleda-VelasquezJF
Artavanis-TsakonasS
2006 CADASIL: a critical look at a Notch disease. Dev Neurosci 28 5 12
56. BilguvarK
YasunoK
NiemelaM
RuigrokYM
von Und Zu FraunbergM
2008 Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 40 1472 1477
57. GschwendtnerA
BevanS
ColeJW
PlourdeA
MatarinM
2009 Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 65 531 539
58. 1995 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 1581 1587
59. 1997 The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 349 1569 1581
60. MayerSA
BrunNC
BegtrupK
BroderickJ
DavisS
2005 Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 777 785
61. MendelowAD
GregsonBA
FernandesHM
MurrayGD
TeasdaleGM
2005 Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 387 397
62. HackeW
AlbersG
Al-RawiY
BogousslavskyJ
DavalosA
2005 The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 66 73
63. AlexandrovAV
MolinaCA
GrottaJC
GaramiZ
FordSR
2004 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 2170 2178
64. 2006 Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 1 245 249
65. LeesKR
ZivinJA
AshwoodT
DavalosA
DavisSM
2006 NXY-059 for acute ischemic stroke. N Engl J Med 354 588 600
66. 1978 A randomized trial of aspirin and sulfinpyrazone in threatened stroke. The Canadian Cooperative Study Group. N Engl J Med 299 53 59
67. DienerHC
CunhaL
ForbesC
SiveniusJ
SmetsP
1996 European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 1 13
68. CAPRIE Steering Committee 1996 A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 1329 1339
69. 1993 Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 342 1255 1262
70. 1991 Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 445 453
71. 1991 MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 337 1235 1243
72. 2001 Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 1033 1041
73. AmarencoP
BogousslavskyJ
CallahanA
GoldsteinLB
HennericiM
2006 High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355 549 559
74. YadavJS
WholeyMH
KuntzRE
FayadP
KatzenBT
2004 Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 1493 1501
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 3
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- BMI and Risk of Serious Upper Body Injury Following Motor Vehicle Crashes: Concordance of Real-World and Computer-Simulated Observations
- Unravelling the Genetics of Ischaemic Stroke
- Human Resource and Funding Constraints for Essential Surgery in District Hospitals in Africa: A Retrospective Cross-Sectional Survey
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials